TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Olink Proteomics AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,492,713
|
1,284,315
|
760,758 |
| Financial expenses |
49,450
|
4,479
|
7 |
| Earnings before taxes |
-91,233
|
4,336
|
-83,769 |
| EBITDA |
-15,152
|
23,076
|
-74,939 |
| Total assets |
1,899,508
|
1,188,106
|
995,442 |
| Current assets |
1,080,986
|
859,606
|
724,106 |
| Current liabilities |
287,497
|
830,681
|
631,122 |
| Equity capital |
1,612,011
|
357,425
|
364,321 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
362
|
289
|
183 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
84.9%
|
30.1%
|
36.6% |
| Turnover per employee |
4,124
|
4,444
|
4,157 |
| Profit as a percentage of turnover |
-6.1%
|
0.3%
|
-11.0% |
| Return on assets (ROA) |
-2.2%
|
0.7%
|
-8.4% |
| Current ratio |
376.0%
|
103.5%
|
114.7% |
| Return on equity (ROE) |
-5.7%
|
1.2%
|
-23.0% |
| Change turnover |
117,268
|
546,421
|
281,129 |
| Change turnover % |
9%
|
74%
|
59% |
| Chg. No. of employees |
73
|
106
|
53 |
| Chg. No. of employees % |
25%
|
58%
|
41% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.